Study of a new drug with a common cholesterol medicine
Treatments studied
This study tests how a new investigational drug, MK-4646, affects the levels of a common cholesterol medicine called rosuvastatin in healthy people. It helps researchers understand if the two drugs can be taken together safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in good general health
- You are between 18 and 32 on the body mass index (BMI) scale
- You have no significant medical conditions such as heart, liver, kidney, or neurological diseases
- You have never had cancer
- You have no history of muscle problems like myopathy or rhabdomyolysis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how a new drug called Enlicitide (MK-0616) interacts with a common cholesterol-lowering drug, Rosuvastatin. It is for healthy adults to check safety and how the drugs work together.
This trial tests a new medicine called MK-1406 in healthy volunteers to make sure it's safe before it can be studied in patients. If you're generally healthy, you could help advance medical research.
This trial tests a new medicine called MK-4082 in healthy people to see how safe it is and how the body handles it. It may help understand if the drug could be used for future treatments.
This study tests a new drug called RO7795081 to see if it changes how your body handles two common statins (pitavastatin and rosuvastatin). It is for adults who are overweight or obese but otherwise healthy, and aims to check the safety of the new drug.
This study tests how a new drug moves through the body and affects cholesterol levels. It is for people with moderately high cholesterol who are otherwise healthy.
This early study tests whether “liver fat” changes how a statin (rosuvastatin) works in children and teens. It may help doctors choose safer or more effective dosing in kids based on biology and a specific genetics marker.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.